Copyright Reports & Markets. All rights reserved.

Global Cytomegalovirus ELISA Kits Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Cytomegalovirus ELISA Kits Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 IgG
    • 1.3.3 IgM
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Cytomegalovirus ELISA Kits Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Laboratory
    • 1.4.3 Colleges
    • 1.4.4 Others
  • 1.5 Global Cytomegalovirus ELISA Kits Market Size & Forecast
    • 1.5.1 Global Cytomegalovirus ELISA Kits Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Cytomegalovirus ELISA Kits Sales Quantity (2021-2032)
    • 1.5.3 Global Cytomegalovirus ELISA Kits Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 MyBioSource
    • 2.1.1 MyBioSource Details
    • 2.1.2 MyBioSource Major Business
    • 2.1.3 MyBioSource Cytomegalovirus ELISA Kits Product and Services
    • 2.1.4 MyBioSource Cytomegalovirus ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 MyBioSource Recent Developments/Updates
  • 2.2 Biomatik
    • 2.2.1 Biomatik Details
    • 2.2.2 Biomatik Major Business
    • 2.2.3 Biomatik Cytomegalovirus ELISA Kits Product and Services
    • 2.2.4 Biomatik Cytomegalovirus ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Biomatik Recent Developments/Updates
  • 2.3 BosterBio
    • 2.3.1 BosterBio Details
    • 2.3.2 BosterBio Major Business
    • 2.3.3 BosterBio Cytomegalovirus ELISA Kits Product and Services
    • 2.3.4 BosterBio Cytomegalovirus ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 BosterBio Recent Developments/Updates
  • 2.4 Abbexa
    • 2.4.1 Abbexa Details
    • 2.4.2 Abbexa Major Business
    • 2.4.3 Abbexa Cytomegalovirus ELISA Kits Product and Services
    • 2.4.4 Abbexa Cytomegalovirus ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Abbexa Recent Developments/Updates
  • 2.5 BosterBio
    • 2.5.1 BosterBio Details
    • 2.5.2 BosterBio Major Business
    • 2.5.3 BosterBio Cytomegalovirus ELISA Kits Product and Services
    • 2.5.4 BosterBio Cytomegalovirus ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 BosterBio Recent Developments/Updates
  • 2.6 DEMEDITEC Diagnostics
    • 2.6.1 DEMEDITEC Diagnostics Details
    • 2.6.2 DEMEDITEC Diagnostics Major Business
    • 2.6.3 DEMEDITEC Diagnostics Cytomegalovirus ELISA Kits Product and Services
    • 2.6.4 DEMEDITEC Diagnostics Cytomegalovirus ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 DEMEDITEC Diagnostics Recent Developments/Updates
  • 2.7 United States Biological
    • 2.7.1 United States Biological Details
    • 2.7.2 United States Biological Major Business
    • 2.7.3 United States Biological Cytomegalovirus ELISA Kits Product and Services
    • 2.7.4 United States Biological Cytomegalovirus ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 United States Biological Recent Developments/Updates
  • 2.8 Biorbyt
    • 2.8.1 Biorbyt Details
    • 2.8.2 Biorbyt Major Business
    • 2.8.3 Biorbyt Cytomegalovirus ELISA Kits Product and Services
    • 2.8.4 Biorbyt Cytomegalovirus ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Biorbyt Recent Developments/Updates
  • 2.9 Novus Biologicals
    • 2.9.1 Novus Biologicals Details
    • 2.9.2 Novus Biologicals Major Business
    • 2.9.3 Novus Biologicals Cytomegalovirus ELISA Kits Product and Services
    • 2.9.4 Novus Biologicals Cytomegalovirus ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Novus Biologicals Recent Developments/Updates
  • 2.10 IBL
    • 2.10.1 IBL Details
    • 2.10.2 IBL Major Business
    • 2.10.3 IBL Cytomegalovirus ELISA Kits Product and Services
    • 2.10.4 IBL Cytomegalovirus ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 IBL Recent Developments/Updates
  • 2.11 XpressBio
    • 2.11.1 XpressBio Details
    • 2.11.2 XpressBio Major Business
    • 2.11.3 XpressBio Cytomegalovirus ELISA Kits Product and Services
    • 2.11.4 XpressBio Cytomegalovirus ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 XpressBio Recent Developments/Updates
  • 2.12 Abnova Corporation
    • 2.12.1 Abnova Corporation Details
    • 2.12.2 Abnova Corporation Major Business
    • 2.12.3 Abnova Corporation Cytomegalovirus ELISA Kits Product and Services
    • 2.12.4 Abnova Corporation Cytomegalovirus ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Abnova Corporation Recent Developments/Updates
  • 2.13 Wuhan Fine Biotech
    • 2.13.1 Wuhan Fine Biotech Details
    • 2.13.2 Wuhan Fine Biotech Major Business
    • 2.13.3 Wuhan Fine Biotech Cytomegalovirus ELISA Kits Product and Services
    • 2.13.4 Wuhan Fine Biotech Cytomegalovirus ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Wuhan Fine Biotech Recent Developments/Updates

3 Competitive Environment: Cytomegalovirus ELISA Kits by Manufacturer

  • 3.1 Global Cytomegalovirus ELISA Kits Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Cytomegalovirus ELISA Kits Revenue by Manufacturer (2021-2026)
  • 3.3 Global Cytomegalovirus ELISA Kits Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Cytomegalovirus ELISA Kits by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Cytomegalovirus ELISA Kits Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Cytomegalovirus ELISA Kits Manufacturer Market Share in 2025
  • 3.5 Cytomegalovirus ELISA Kits Market: Overall Company Footprint Analysis
    • 3.5.1 Cytomegalovirus ELISA Kits Market: Region Footprint
    • 3.5.2 Cytomegalovirus ELISA Kits Market: Company Product Type Footprint
    • 3.5.3 Cytomegalovirus ELISA Kits Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Cytomegalovirus ELISA Kits Market Size by Region
    • 4.1.1 Global Cytomegalovirus ELISA Kits Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Cytomegalovirus ELISA Kits Consumption Value by Region (2021-2032)
    • 4.1.3 Global Cytomegalovirus ELISA Kits Average Price by Region (2021-2032)
  • 4.2 North America Cytomegalovirus ELISA Kits Consumption Value (2021-2032)
  • 4.3 Europe Cytomegalovirus ELISA Kits Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Cytomegalovirus ELISA Kits Consumption Value (2021-2032)
  • 4.5 South America Cytomegalovirus ELISA Kits Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Cytomegalovirus ELISA Kits Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Cytomegalovirus ELISA Kits Sales Quantity by Type (2021-2032)
  • 5.2 Global Cytomegalovirus ELISA Kits Consumption Value by Type (2021-2032)
  • 5.3 Global Cytomegalovirus ELISA Kits Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Cytomegalovirus ELISA Kits Sales Quantity by Application (2021-2032)
  • 6.2 Global Cytomegalovirus ELISA Kits Consumption Value by Application (2021-2032)
  • 6.3 Global Cytomegalovirus ELISA Kits Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Cytomegalovirus ELISA Kits Sales Quantity by Type (2021-2032)
  • 7.2 North America Cytomegalovirus ELISA Kits Sales Quantity by Application (2021-2032)
  • 7.3 North America Cytomegalovirus ELISA Kits Market Size by Country
    • 7.3.1 North America Cytomegalovirus ELISA Kits Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Cytomegalovirus ELISA Kits Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Cytomegalovirus ELISA Kits Sales Quantity by Type (2021-2032)
  • 8.2 Europe Cytomegalovirus ELISA Kits Sales Quantity by Application (2021-2032)
  • 8.3 Europe Cytomegalovirus ELISA Kits Market Size by Country
    • 8.3.1 Europe Cytomegalovirus ELISA Kits Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Cytomegalovirus ELISA Kits Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Cytomegalovirus ELISA Kits Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Cytomegalovirus ELISA Kits Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Cytomegalovirus ELISA Kits Market Size by Region
    • 9.3.1 Asia-Pacific Cytomegalovirus ELISA Kits Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Cytomegalovirus ELISA Kits Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Cytomegalovirus ELISA Kits Sales Quantity by Type (2021-2032)
  • 10.2 South America Cytomegalovirus ELISA Kits Sales Quantity by Application (2021-2032)
  • 10.3 South America Cytomegalovirus ELISA Kits Market Size by Country
    • 10.3.1 South America Cytomegalovirus ELISA Kits Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Cytomegalovirus ELISA Kits Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Cytomegalovirus ELISA Kits Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Cytomegalovirus ELISA Kits Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Cytomegalovirus ELISA Kits Market Size by Country
    • 11.3.1 Middle East & Africa Cytomegalovirus ELISA Kits Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Cytomegalovirus ELISA Kits Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Cytomegalovirus ELISA Kits Market Drivers
  • 12.2 Cytomegalovirus ELISA Kits Market Restraints
  • 12.3 Cytomegalovirus ELISA Kits Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Cytomegalovirus ELISA Kits and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Cytomegalovirus ELISA Kits
  • 13.3 Cytomegalovirus ELISA Kits Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Cytomegalovirus ELISA Kits Typical Distributors
  • 14.3 Cytomegalovirus ELISA Kits Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Cytomegalovirus ELISA Kits market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Cytomegalovirus (CMV) ELISA Kits are diagnostic tools used to detect and quantify CMV in biological samples such as blood, urine, and saliva. CMV is a common herpesvirus that can cause serious health complications particularly in immunocompromised individuals. These ELISA Kits use specific antibodies to bind to the viral antigens, allowing for the detection and quantification of CMV in the sample. The results of the CMV ELISA Kit can be used to diagnose and monitor CMV infections, as well as to monitor the efficacy of antiviral therapies.
    The industry trend for CMV ELISA Kits is driven by the growing need for accurate and reliable diagnostic tools for CMV infections. As CMV becomes an increasingly recognized cause of morbidity and mortality, particularly in immunocompromised populations, the demand for efficient diagnostic tools has increased. The industry is focusing on developing novel and sensitive CMV ELISA Kits that can detect both active and latent infections. Additionally, there a growing interest in developing multiplex CMV assays that can detect multiple strains of the virus simultaneously, providing a more comprehensive understanding of the infection. The industry trend is also towards developing user-friendly and rapid CMV ELISA Kits that can be used in both research and clinical settings, enabling more rapid diagnosis and treatment.
    This report is a detailed and comprehensive analysis for global Cytomegalovirus ELISA Kits market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Cytomegalovirus ELISA Kits market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Cytomegalovirus ELISA Kits market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Cytomegalovirus ELISA Kits market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Cytomegalovirus ELISA Kits market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Cytomegalovirus ELISA Kits
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Cytomegalovirus ELISA Kits market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MyBioSource, Biomatik, BosterBio, Abbexa, BosterBio, DEMEDITEC Diagnostics, United States Biological, Biorbyt, Novus Biologicals, IBL, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Cytomegalovirus ELISA Kits market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    IgG
    IgM
    Market segment by Application
    Laboratory
    Colleges
    Others
    Major players covered
    MyBioSource
    Biomatik
    BosterBio
    Abbexa
    BosterBio
    DEMEDITEC Diagnostics
    United States Biological
    Biorbyt
    Novus Biologicals
    IBL
    XpressBio
    Abnova Corporation
    Wuhan Fine Biotech
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Cytomegalovirus ELISA Kits product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Cytomegalovirus ELISA Kits, with price, sales quantity, revenue, and global market share of Cytomegalovirus ELISA Kits from 2021 to 2026.
    Chapter 3, the Cytomegalovirus ELISA Kits competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Cytomegalovirus ELISA Kits breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Cytomegalovirus ELISA Kits market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Cytomegalovirus ELISA Kits.
    Chapter 14 and 15, to describe Cytomegalovirus ELISA Kits sales channel, distributors, customers, research findings and conclusion.

    Buy now